A clinical trial is a systematic investigation of a medicinal product intended to gather or confirm knowledge on efficacy, interaction, adverse reaction and pharmacokinetics or investigate its medicinal value.
Regulation. 443/2004 on clinical trials, which came into force in May 2004, implements Directive 2001/20/EC as well as Directive 2001/83/EC on medicinal products for humans. Directive 2001/20/EC applies to all of the European Economic Area (EEA) and guidelines on a common European website (EudraCT) apply in Iceland as well as in the other EEA countries. At the website a link can also be found to an application form, which needs to be filled in for applying for a clinical trial in Iceland.
The following items should be considered when applying
- The Regulation does not apply to non-interventional investigation
- The Regulation covers bioavailability and bioequivalence studies
- The Regulation applies to radioactive medicines, natural medicines, homeopathic medicines, medicines for gene-therapy or for remedy with body cells and medicines, which contain genetically modified organisms
- All medicines (substances/products) to be investigated must be manufactured according to the principles of Good Manufacturing Practice (GMP)
The Helsinki Declaration from 1996 must be observed on the protection on individuals unable to give informed consent, surveillance of adverse effects etc.